شرکت سرمایه گذاری داروئی تامین
@i_16012
What symbols does the trader recommend buying?
Purchase History
پیام های تریدر
Filter
Signal Type
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 2289.978 million drugs on 140/06/05 and currently accounts for 4.654 % of the drug's shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Caspian Pharmaceutical Investment Company purchased 4747.100 million shares on 29/05/29 and currently holds 72.585 % of Caspian shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 947.655 million shares on 26/05/26 and currently accounts for 12.459 % of Dafara's shares in its portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 3254.644 million shares of Hijra on 14/05/22 and currently holds 17.084 % of Hijra's shares in its portfolio.
شرکت سرمایه گذاری داروئی تامین
Deller's 1974.892 Million Pharmaceutical Investment Company bought Deller's shares on 14/05/11 and currently holds 28.346 % of Deller's shares in its portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 4812,200 million shares of Clare on 14/05/06 and currently accounts for 71.723 % of Clare's shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company has sold 0.500 million shares on 21/04/21 and currently accounts for 70.283 % of Deppars in its portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company has bought 1797.007 million shares on 24/03/24 and currently holds 24.186 % of Delzharavi shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 1797.007 million shares on 21/03/21 and currently holds 24.186 % of Delzharavi shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 2249.623 million shares on 14/02/16 and currently accounts for 7.977 % of the discharge shares in its joint portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.